Targeted screening Cellecta offers HT loss-of-function genetic screening services with pooled lentiviral shRNA and CRISPR libraries, presenting a strong opportunity to cross-sell target discovery and functional validation services to biopharma clients seeking novel targets.

Immune profiling Recent launches of DriverMap AIR TCR and BCR kits enable sensitive immune repertoire profiling, suggesting upsell potential to immuno-oncology and autoimmune research groups requiring deep lymphocyte receptor analysis.

CRISPR and species expansion The introduction of genome-wide CRISPR Chicken and Pig Knockout Libraries expands screening capabilities across non-mouse models, opening doors for translational studies and comparative biology collaborations with CROs and academic labs.

Tissue to target Strategic partnerships like Tissue 2 Target with Cureline strengthen translational workflows from biospecimens to molecular analysis, presenting opportunities to co-market integrated preclinical services to pharma sponsors and contract research networks.

Clinical translational alignment DriverMap AIR-DNA and associated RNA/DNA profiling offerings support translational medicine initiatives, suggesting sales angles around biomarker discovery, patient stratification, and early-phase biomarker-enabled clinical programs.